Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Participants reporting higher yogurt intake were more likely to have higher intakes of total folate, calcium, and vitamin D, to have higher prevalence in history of sigmoidoscopy/endoscopy screening, to be more physically active, and were less likely to smoke or consume processed and red meat.

Source: Characteristics of study participants. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cohort study.

Cohort study

Examines exposures and outcomes over time within a defined group.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

This study was based on two ongoing U.S.-wide prospective cohort studies, namely the Nurses’ Health Study (NHS) and the Health Professionals Follow-up Study (HPFS) (), and the prospective cohort incident-tumor biobank method (PCIBM).

Source: Methods.

Participants were categorized according to the cumulative average of yogurt intake (<1 serving/month, 1 to 3 servings/month, 1 serving/week, and ≥ 2 servings/week).

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Long-term yogurt intake and colorectal cancer incidence subclassified by Bifidobacterium abundance in tumor

Cohort study · Gut Microbes · 2025

Original publication title

Long-term yogurt intake and colorectal cancer incidence subclassified by Bifidobacterium abundance in tumor

Satoko Ugai; Li Liu; Keisuke Kosumi; Hidetaka Kawamura; Tsuyoshi Hamada; Kosuke Mima; Kota Arima; Kazuo Okadome; Qian Yao; Kosuke Matsuda; Yuxue Zhong; Hiroki Mizuno; Andrew T. Chan; Wendy S. Garrett; Mingyang Song; Marios Giannakis; Edward L. Giovannucci; Xuehong Zhang; Shuji Ogino; Tomotaka Ugai

© 2025 The Author(s). Published with license by Taylor & Francis Group, LLC.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

ABSTRACT

Evidence suggests a tumor-suppressive effect of the intake of yogurt, which typically contains Bifidobacterium. We hypothesized that long-term yogurt intake might be associated with colorectal cancer incidence differentially by tumor subgroups according to the amount of tissue Bifidobacterium. We utilized the prospective cohort incident-tumor biobank method and resources of two prospective cohort studies. Inverse probability weighted multivariable Cox proportional hazards regression was used to assess differential associations of yogurt intake with the incidence of colorectal carcinomas subclassified by the abundance of tumor tissue Bifidobacterium.

During follow-up of 132,056 individuals, we documented 3,079 incident colorectal cancer cases, including 1,121 with available tissue Bifidobacterium data. The association between long-term yogurt intake and colorectal cancer incidence differed by Bifidobacterium abundance (P heterogeneity = 0.0002). Multivariable-adjusted hazard ratios (HRs) (with 95% confidence intervals) in individuals who consumed ≥2 servings/week (vs. <1 serving/month) of yogurt were 0.80 (0.50 to 1.28) for Bifidobacterium-positive tumor and 1.09 (0.81 to 1.46) for Bifidobacterium-negative tumor. This differential association was also observed in a subgroup analysis of proximal colon cancer (P heterogeneity = 0.018).

Long-term yogurt intake may be differentially associated with the incidence of proximal colon cancer according to Bifidobacterium abundance, suggesting the antitumor effect of yogurt intake on the specific tumor subgroup.

Authors’ abstract

ABSTRACT

Evidence suggests a tumor-suppressive effect of the intake of yogurt, which typically contains Bifidobacterium. We hypothesized that long-term yogurt intake might be associated with colorectal cancer incidence differentially by tumor subgroups according to the amount of tissue Bifidobacterium. We utilized the prospective cohort incident-tumor biobank method and resources of two prospective cohort studies. Inverse probability weighted multivariable Cox proportional hazards regression was used to assess differential associations of yogurt intake with the incidence of colorectal carcinomas subclassified by the abundance of tumor tissue Bifidobacterium.

During follow-up of 132,056 individuals, we documented 3,079 incident colorectal cancer cases, including 1,121 with available tissue Bifidobacterium data. The association between long-term yogurt intake and colorectal cancer incidence differed by Bifidobacterium abundance (P heterogeneity = 0.0002). Multivariable-adjusted hazard ratios (HRs) (with 95% confidence intervals) in individuals who consumed ≥2 servings/week (vs. <1 serving/month) of yogurt were 0.80 (0.50 to 1.28) for Bifidobacterium-positive tumor and 1.09 (0.81 to 1.46) for Bifidobacterium-negative tumor. This differential association was also observed in a subgroup analysis of proximal colon cancer (P heterogeneity = 0.018).

Long-term yogurt intake may be differentially associated with the incidence of proximal colon cancer according to Bifidobacterium abundance, suggesting the antitumor effect of yogurt intake on the specific tumor subgroup.

Publication and source details

Original title: Long-term yogurt intake and colorectal cancer incidence subclassified by Bifidobacterium abundance in tumor

Satoko Ugai; Li Liu; Keisuke Kosumi; Hidetaka Kawamura; Tsuyoshi Hamada; Kosuke Mima; Kota Arima; Kazuo Okadome; Qian Yao; Kosuke Matsuda; Yuxue Zhong; Hiroki Mizuno; Andrew T. Chan; Wendy S. Garrett; Mingyang Song; Marios Giannakis; Edward L. Giovannucci; Xuehong Zhang; Shuji Ogino; Tomotaka Ugai

Gut Microbes · 2025

CONTACT Tomotaka Ugai tugai@bwh.harvard.eduShuji Ogino sogino@bwh.harvard.edu Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women’s Hospital, 221 Longwood Ave., EBRC Room 404, Boston, MA 02215, USA
*

The first four authors contributed equally as co-first authors.

#

The last two authors contributed equally as co-last authors.

© 2025 The Author(s). Published with license by Taylor & Francis Group, LLC.2025The Author(s)https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T06:45:16.483002+00:00

DOI: 10.1080/19490976.2025.2452237 · PMC11834522